Soluble CD33 for treating myelodysplastic syndromes (MDS) Grant US-11584787-B2 United States of America 21 Feb 2023
Soluble CD33 for treating myelodysplastic syndromes (MDS) Grant US-10344072-B2 United States of America 09 Jul 2019
Methods and compositions for enhancing an immune response, blocking monocyte migration… Grant US-10206983-B2 United States of America 19 Feb 2019
VACCINE COMPRISING MONOCYTE OR IMMATURE MYELOID CELLS(IMC) WHICH WERE LOADED WITH THE… Grant EP-2227253-B1 European Patent Office 17 May 2017